Potentiation of antitumour activity of docetaxel by combination with trastuzumab in a human prostate cancer xenograft model and underlying mechanisms.
about
Progress of molecular targeted therapies for prostate cancersThe RNA-binding protein HuR opposes the repression of ERBB-2 gene expression by microRNA miR-331-3p in prostate cancer cellsSerially heterotransplanted human prostate tumours as an experimental modelEGFR ligand switch in late stage prostate cancer contributes to changes in cell signaling and bone remodeling.Inhibitory effects of Rhenium-188-labeled Herceptin on prostate cancer cell growth: a possible radioimmunotherapy to prostate carcinoma.d -Limonene sensitizes docetaxel-induced cytotoxicity in human prostate cancer cells: Generation of reactive oxygen species and induction of apoptosis.[Sequence-dependent effect of docetaxel with gefitinib on the proliferation and signal protein expression of human lung adenocarcinoma cell SPC-A1].
P2860
Q26823014-D6241FF6-73F4-4593-A122-3E71AA24284BQ35842164-A657669C-835E-4393-9705-08A55ED57F2BQ37310963-3B45990D-68EA-4FF1-AF44-E5549972DF06Q37397897-F181A099-E695-41D8-AFB5-B101549103A9Q39215370-ECE94C0C-2230-40D9-B2B7-5B6E39F3E96CQ41292697-C8B938B4-C728-4832-91E7-7194A6343472Q54590223-ECDB6472-0580-4B8E-89E0-130F0F1CE2F7
P2860
Potentiation of antitumour activity of docetaxel by combination with trastuzumab in a human prostate cancer xenograft model and underlying mechanisms.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Potentiation of antitumour act ...... del and underlying mechanisms.
@en
Potentiation of antitumour act ...... del and underlying mechanisms.
@nl
type
label
Potentiation of antitumour act ...... del and underlying mechanisms.
@en
Potentiation of antitumour act ...... del and underlying mechanisms.
@nl
prefLabel
Potentiation of antitumour act ...... del and underlying mechanisms.
@en
Potentiation of antitumour act ...... del and underlying mechanisms.
@nl
P2093
P2860
P356
P1476
Potentiation of antitumour act ...... del and underlying mechanisms.
@en
P2093
B Dutrillaux
G de Pinieux
M-E Legrier
M-F Poupon
P de Cremoux
P2860
P2888
P304
P356
10.1038/SJ.BJC.6603553
P407
P577
2007-01-09T00:00:00Z
P5875
P6179
1038800754